Marv D. Shepherd, PhD
PSM PSA: Have You Received a Blast Fax Offering Cheap Medication?
Blast-faxes sent to doctors’ offices are the subject of the latest public service announcement from the Partnership for Safe Medicines In Have You Gotten a Blast Fax Offering Cheap Medication? PSM board member Dr. Marv Shepherd warns physicians to be wary of too-good-to-be-true medications prices in blast-fax offerings.
[...]Dr. Marv Shepherd Explains the New USP Good Distribution Practices at Interchange 2014
Dr. Marv Shepherd Explains the New USP Good Distribution Practices at Interchange 2014 At Partnership for Safe Medicines Interchange 2014 in Washington D.C. PSM Board member Dr. Marv Shepherd shared some of the details of the U.S. Pharmacopeia’s soon-to-be-released packaging and distribution updates to its National Formulary.
[...]PSM Board Member Dr. Marv Shepherd Speaks with CBS News About Pharmacy Errors
When CBS Dallas reported on prescription fulfillment errors in Texas pharmacies, they reached out to The Partnership for Safe Medicine’s Board President, Dr. Marvin D. Shepherd to discuss the prevention of dispensing errors. Dr. Shepherd is Director of the Center for Pharmacoeconomic Studies and Chairman of the Pharmacy Administration Division at the University of Texas…
[...]Interchange 2013 Highlights: Dr. Marvin Shepherd of University of Texas at Austin Pharmacoeconomic Studies Program
Nemlekar P, Shepherd M*, Lawson K, and Rush S. Web-Based Survey to Assess the Perceptions of Managed Care Organization Representatives on Use of Copay Subsidy Coupons for Prescription Drugs. J Manag Care Pharm. 2013;19(8):602-08.
ABSTRACT BACKGROUND: Promotion of prescription drug coupons and vouchers by pharmaceutical manufacturers has increased in recent years. These coupons and vouchers usually subsidize patients’ cost-sharing obligations. In other words, drug companies pay for a patient’s portion of the drug cost, and the remaining cost is paid by the patient and the patient’s health plan. This…
[...]Shepherd M*. Examination of Why Some Community Pharmacists Do Not Provide 72-Hour Emergency Prescription Drugs to Medicaid Patients When Prior Authorization Is Not Available. J Manag Care Pharm. 2013;19(7):523-33.
BACKGROUND: Existing federal law requires that a 72-hour emergency supply of a prescription drug be dispensed to Medicaid patients when prior authorization (PA) is not available and the medication is needed without delay. The pharmacist’s role is to contact prescribers and inform them that PA is needed. If the prescriber cannot be reached, the pharmacist can dispense a 72-hour emergency supply.
OBJECTIVES: To determine (a) the reasons why some community pharmacy owners/managers, staff pharmacists, and technicians are not compliant with the law; (b) how often the decision is made; and (c) estimate how often pharmacies do not dispense the 72-hour emergency supply when PA is not available.
[...]Chambliss W. G, Carroll W. A, Kennedy D, Shepherd M*, et al. Role of the Pharmacist in Preventing Distribution of Counterfeit Medications. In: J Am Pharm Assoc. 2012;52(2):195-199.
Abstract Objective: To provide an overview of the counterfeit medication problem and recommendations of a joint American Pharmacists Association (APhA) Academy of Pharmaceutical Research and Science and APhA Academy of Pharmacy Practice and Management taskforce. Date sources: SciFinder and PubMed were searched from 1980 to March 2011 using the following keywords: counterfeit drug product, counterfeit…
[...]Anti-counterfeiting Initiative: Promoting the Quality of Medicines
As incidents and awareness surrounding illicit and counterfeit drugs grows, so too do the programs and technologies to combat them. Over the next few weeks, we’ll be examining just that: anti-counterfeit technologies and the programs designed to support them. While there’s no silver bullet technology or program to mitigate the global threat of counterfeit drugs,…
[...]Across the Pond: Counterfeit Medicines in the UK
Lately, we’ve posted a lot about counterfeit drug issues in the U.S., as well as our recommendations to government agencies on how to better protect Americans from this growing threat to public health. Other developed nations are addressing the same problems. In January, the United Kingdom’s (UK) Parliamentary Office of Science and Technology (POST) published…
[...]Shepherd M.* Beef up international cooperation on counterfeits. Nat Med. 2010;16(4):366.
Counterfeit drugs are a menacing and deadly problem worldwide. The proliferation of fake drugs is astounding, with over 100 countries reporting incidents of fake drugs, according to a 2008 report from the Pharmaceutical Security Institute. And incidents of drug counterfeiting show no evidence of declining: some industry insiders suggest that the number of counterfeit medicines…
[...]